Intuitive Surgical Stock: Buy, Sell, or Hold?

Intuitive Surgical (NASDAQ: ISRG) reported exceptional fourth-quarter and full-year 2025 results earlier this year. Revenue and procedure volumes grew at robust double-digit rates as the company continued rolling out its new da Vinci 5 systems to hospitals.But at a sky-high valuation, does the underlying business momentum justify the stock's price, or are investors better off waiting for a potential pullback?Let's take a closer look at the medical device maker's recent financial results and its valuation to see whether the stock is a buy, sell, or hold today.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool